Conroy Kevin T — SEC Form 4 filings
SEC reporting owner CIK 1306119. 21 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-02-16 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 19,500 shares, $1,001,325 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 47,020 shares, $2,822,340 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 77.
- Largest priced transaction: purchase of 19,500 shares @ $51.35 ($1,001,325) in EXACT SCIENCES CORP, filed 2024-11-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EXACT SCIENCES CORP (EXAS) | President and CEO, Director | 16 | 1 leg · 19,500 sh · $1,001,325 | 6 legs · 47,020 sh · $2,822,340 | 66 |
| ALIGN TECHNOLOGY INC (ALGN) | Director | 3 | — | — | 9 |
| ABBOTT LABORATORIES (ABT) | Director | 2 | — | — | 2 |
Form 4 filings — Conroy Kevin T
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 231 (derivative) @ $90.74 | EDGAR |
| 2026-05-22 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 1,745 @ $0 · Option exercise (M): 1,745 (derivative) @ $0 · Grant/award (A): 1,836 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 2,286 @ $0 | EDGAR |
| 2026-03-23 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 119,312 @ $0 · Disposition to issuer (D): 1,397,738 · Disposition to issuer (D): 29,061 · Disposition to issuer (D): 46,538 · Disposition to issuer (D): 86,750 · Disposition to issuer (D): 117,427 · +8 more | EDGAR |
| 2026-03-03 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 18,143 @ $0 · Tax withholding (F): 8,528 @ $103.25 · Option exercise (M): 22,168 @ $0 · Tax withholding (F): 10,419 @ $103.25 · Option exercise (M): 27,786 @ $0 · Tax withholding (F): 13,060 @ $103.25 · +3 more | EDGAR |
| 2026-02-27 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 13,181 @ $0 · Tax withholding (F): 6,196 @ $103.45 · Grant/award (A): 154,829 (derivative) @ $0 | EDGAR |
| 2025-12-30 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 244,931 @ $0 · Tax withholding (F): 115,118 @ $101.82 · Grant/award (A): 138,326 @ $0 · Tax withholding (F): 65,014 @ $101.82 · Grant/award (A): 330,674 @ $0 · Tax withholding (F): 155,417 @ $101.82 | EDGAR |
| 2025-05-22 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 1,148 @ $0 · Option exercise (M): 1,148 (derivative) @ $0 · Grant/award (A): 1,745 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 66,723 @ $22.38 · Tax withholding (F): 48,929 @ $47.06 · Option exercise (M): 66,723 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 18,143 @ $0 · Tax withholding (F): 8,528 @ $47.82 · Option exercise (M): 22,167 @ $0 · Tax withholding (F): 10,419 @ $47.82 · Option exercise (M): 18,143 (derivative) @ $0 · Option exercise (M): 22,167 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 13,180 @ $0 · Tax withholding (F): 6,195 @ $51.28 · Grant/award (A): 111,146 (derivative) @ $0 · Option exercise (M): 13,180 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 10,374 @ $0 · Tax withholding (F): 3,271 @ $49.63 · Grant/award (A): 48,044 @ $0 · Tax withholding (F): 21,140 @ $50.48 · Option exercise (M): 10,374 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | EXACT SCIENCES CORP (EXAS) | Purchase (P): 19,500 @ $51.35 | EDGAR |
| 2024-05-24 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 660 @ $0 · Option exercise (M): 660 (derivative) @ $0 · Grant/award (A): 1,148 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 2,489 @ $0 · Grant/award (A): 708 @ $30.02 · Sale (S): 1,155 @ $60.15 | EDGAR |
| 2024-03-04 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 18,143 @ $0 · Sale (S): 8,271 @ $59.32 · Option exercise (M): 18,143 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 13,181 @ $0 · Sale (S): 6,263 @ $56.89 · Option exercise (M): 13,181 (derivative) @ $0 · Grant/award (A): 88,671 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 102,837 @ $13.96 · Tax withholding (F): 61,560 @ $57.53 · Option exercise (M): 102,837 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 23,238 @ $0 · Sale (S): 11,565 @ $59.78 | EDGAR |
| 2024-02-22 | 4 | EXACT SCIENCES CORP (EXAS) | Option exercise (M): 10,374 @ $0 · Sale (S): 4,975 @ $61.50 · Option exercise (M): 10,374 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 709 @ $30.02 · Option exercise (M): 31,133 @ $0 · Sale (S): 14,791 @ $61.43 · Option exercise (M): 31,133 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1306119 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →